Skip to content

Maternal and Fetal Outcome of CKD Mother Patient in Sohag Governorate

Maternal and Fetal Outcome of CKD Mother Patient in Sohag Governorate

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05867459
Enrollment
30
Registered
2023-05-22
Start date
2023-04-01
Completion date
2023-12-31
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD PREGNANT WOMEN

Brief summary

Aim of the work: In this study, we aimed: Is to investigate the following issues: (1) the pregnancy outcomes of patients with CKD (2) additional risk factors for adverse pregnancy outcomes in patients with CKD in the area of sohag governorate.

Detailed description

prospective observational study including group of pregnant CKD women The Group of pregnant CKD PT as mentioned in introduction and according to KIDOG definition of CKD regardless cause of CKD . The data will be collected by multiple visit and survey of patient in hemodialysis units in sohag governorate and renal outpatient clinic and obstetric department and internal medicine department in sohag university hospital Duration of study: nine month after approval of protocol by medical research committee of sohag faculty of medicine Data collection procedure: The following clinical data will be collected: Clinical assessment: age, kidney disease history, history of DM or HTN ,history of pregnancy during study, therapy in early pregnancy (including antihypertensive drugs and immunosuppressive agents), , baseline blood pressure, body weight, body height, and . Mean arterial pressure (MAP) was calculated as (systolic pressure+2×diastolic pressure)/3. Body mass index (BMI) was calculated based on height and body weight. According to age and Scr level, the estimated glomerular filtration rate (eGFR) was calculated by CKD-EPI Creatinine Equation (2021) Evaluation of pregnancy outcomes :Adverse pregnancy outcomes included maternal death, severe preeclampsia ,eclampsia ,duration of hospital stay and type of care need, mode of delivery ,need of blood transfusion , gestational age during delivary for detet preterm birth\> 37W early preterm from 28 to 34W or late preterm from 34 to37W or extremely preterm \> 28W, birth weigh for low birthweight\> 2500 g ,very low birth weight \>1500g , extremely low birth weight\>1000g,NICU admission,IUGR, still birth ,abortion, and neonatal death. Laboratory assessment: 1. serum creatinine 2. urine analysis 3-24h protein in urine or albumin create ratio 4-serum electrolyte s.Na s.K ionezed Ca 5-pathological result of renal biopsy if done 6-abdominal ultrasound with full comment on kidney

Interventions

DIAGNOSTIC_TESTSerum creatinine

The test wil be measured for all pt in study to detect of their grade of CKD

DIAGNOSTIC_TESTAlb /creat ratio or 24h urine protein

Test will be measured to detect type and sevirity of proteinuria

DIAGNOSTIC_TESTSerum electrolyte

The test will be measured in all pt to detect renal tubular state

DIAGNOSTIC_TESTUrine analysis

It is mirror of kidney

DIAGNOSTIC_TESTAbdominal ultrasound

To detect the anatomy and any structural abnormality in kidneys

DIAGNOSTIC_TESTRenal biobsy

Is done but not for all pt but for pt that can do it and agree for it .the test is used for detection of type of CKD or type of glomerionephritis

Clinical assessment: age, kidney disease history, history of DM or HTN ,history of pregnancy during study, therapy in early pregnancy , body weight, body height, and . Mean arterial pressure (MAP) . Body mass index (BMI). According to age and Scr level, the estimated glomerular filtration rate (eGFR) was calculated by CKD-EPI Creatinine Equation (2021) Evaluation of pregnancy outcomes :Adverse pregnancy outcomes included maternal death, severe preeclampsia ,eclampsia ,duration of hospital stay and type of care need, mode of delivery ,need of blood transfusion , gestational age during delivary for detet preterm birth early preterm or late preterm from or extremely preterm \> 28W, birth weigh for low birthweight ,very low birth weight , extremely low birth weight,NICU admission,IUGR, still birth ,abortion, and neonatal death.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 52 Years
Healthy volunteers
No

Inclusion criteria

* All pregnant patients with CKD regardless the cause of CKD in any stage of CKD on dialysis or not.

Exclusion criteria

* Any patient not defined CKD or serum creatinineless than1,2 befor 13W of pregnancy Grand multipara patient with history of multiple abortion or still birth not related to CKD affection period

Design outcomes

Primary

MeasureTime frameDescription
1) the pregnancy outcomes of patients with CKD (2) additional risk factors for adverse pregnancy outcomes in patients with CKDFrom day of enrollment of pt in study to one week after delivaryMedical and clinial data will collect And retrospectively analyze. The data well collected by multiple visit to pt or telephon calling for follow up data will ensured by report of about pt from obstetric and nicu doctor Evaluation of pregnancy outcomes :Adverse pregnancy outcomes included maternal death, severe preeclampsia ,eclampsia The diagnostic criteria for severe preeclampsia were based on the 2013 Hypertension in Pregnancy Guidelines of the American College of Obstetricians and Gynecologists . duration of hospital stay and type of care need, mode of delivery ,need of blood transfusion , gestational age during delivary for detet preterm birth and its type, birth weigh for detect low birth Wt and its degree ,NICU admission,IUGR as fetus is 10 centile according gastational age, still birth, ,abortion , and neonatal death, any documented congenital anomalies of fetus. And questionaire of pt for risk factor as DM,HTN,maternal age,drug use during delivary, stage of CKD

Countries

Egypt

Contacts

Primary ContactMohamed S Mohamedein, Resident
mohamedsaad@med.sohag.edu.eg01009463244
Backup ContactAdel A El sayed, professor
01006677651

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026